2Macdonald TT, Monteleone G, Render SL. Recent developments in immunology of Inflammatory bowel disease [J] .Scand J Immunol,2000,51 (1) :2-9.
3Venturi A,Gionchetti P,Rizzello F,et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis [J]. Aliment Pharmacol Ther, 1999, 13 ( 8 ):1103-1108.
4Linskens RK,Huijsdens XW,Savelkoul PH. et al. Tthe bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics [J].Scand J Gastroenterol, 2001, (234) : 29-40.
5Balish E,Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice[J]. Am J Pathol,2002,160 ( 6 ): 2253- 2257.
6Malin M, Suomalainen H, Saxelin M, et al. promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG[J]. Ann Nutr Metab,1996,40(3) : 137-145.
7Ko EJ,Goh JS, Lee B J, et al. Bifidobacterium bifidum exhibits a lipopolysaccharide-like mitogenic activity for murine B lymphocytes[J]. J Dairy Sci, 1999,82(9):1869-1876.
8Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? [J]. Inflamm Bowel Dis 2000,6(2):107-105.
